Ascendis Pharma A (ASND) Interest Income - Total (2014 - 2026)

Ascendis Pharma A has reported Interest Income - Total for 13 years, with the latest figure at $5.3 million in Q1 2026.

• Quarterly Interest Income - Total rose 117.43% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$235.7 million (down 74.04% YoY) and the FY2025 annual result came in at -$276.3 million, down 174.53% from the prior year.
• Interest Income - Total rose to $5.3 million in Q1 2026 per ASND's latest filing, from -$171.6 million in the prior quarter.
• Over five years, Interest Income - Total peaked at $10.5 million in Q3 2022 and troughed at -$171.6 million in Q4 2025.
• A 5-year average of -$31.7 million and a median of -$16.3 million in 2024 frame the typical range for Interest Income - Total.
• The sharpest annual moves came in 2022 and 2024: Interest Income - Total soared 141.6% in 2022, then sank 9988.87% in 2024.
• Over 5 years, Interest Income - Total stood at -$8.6 million in 2022, then soared by 92.02% to -$687525.6 in 2023, then tumbled by 9988.87% to -$69.4 million in 2024, then slumped by 147.35% to -$171.6 million in 2025, then jumped by 103.08% to $5.3 million in 2026.
• According to Business Quant data, Interest Income - Total over the past three periods registered $5.3 million, -$171.6 million, and -$7.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.